Canada markets closed

Satsuma Pharmaceuticals, Inc. (STSA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.8500-0.0800 (-1.62%)
At close: 4:00PM EDT

4.8500 0.00 (0.00%)
After hours: 4:00PM EDT

Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
33,778
36,270
24,196
6,433
4,193
Selling General and Administrative
12,829
12,058
4,685
1,082
754
Total Operating Expenses
46,607
48,328
28,881
7,515
4,947
Operating Income or Loss
-46,607
-48,328
-28,881
-7,515
-4,947
Interest Expense
303
350
482
90
15
Total Other Income/Expenses Net
-
-
-1
187
-240
Income Before Tax
-46,241
-47,563
-28,175
-7,346
-5,172
Income from Continuing Operations
-46,241
-47,563
-28,175
-7,346
-5,172
Net Income
-46,241
-47,563
-28,175
-7,346
-5,172
Net Income available to common shareholders
-46,241
-47,563
-28,175
-7,346
-5,172
Basic EPS
-
-
-4.80
-1.86
-0.76
Diluted EPS
-
-
-4.80
-1.86
-0.76
Basic Average Shares
-
-
5,864
3,942
6,802
Diluted Average Shares
-
-
5,864
3,942
6,802
EBITDA
-
-46,974
-27,552
-7,199
-5,147